About me
Bridget Doherty, MPH, MS, is a strategic policy, research, and communications professional with extensive experience in pharmaceuticals, medical devices, and healthcare publishing. Currently serving as the Director of Access and Policy Research at Johnson & Johnson Innovative Medicine, she develops and executes impactful policy research and scientific engagement plans aimed at developing an evidence-based understanding of U.S. healthcare policies’ impact on patients and the healthcare ecosystem. Among her key contributions include the first comprehensive analysis of the FDA Accelerated Approval Program's impact on patient outcomes in oncology, providing evidence that approximately 263,000 life years were gained for cancer patients.
LinkedIn